Medical Devices France

France Leadless Pacemakers Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

France Leadless Pacemakers Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $23.7 Mn Placeholder estimate
Estimate 2025 $26.2 Mn 2.6% of the global market
Projected 2034 $65.5 Mn 149.6% Adds $39.2 Mn over 9 forecast years
CAGR 2025–2034 10.7% Faster than 70% of 173 Medical Devices markets here
Key players 5
  • France is 2.61% of the global market.
  • In Europe, the largest is Germany at $33.4 Mn.
  • Fastest growing: Russia at 12.5% a year.
  • France ranks 4th of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$39.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Leadless Pacemakers Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $23.7 Mn — —
2025 (base) $26.2 Mn +$2.5 Mn —
2026 (forecast) $29.0 Mn +$2.8 Mn +10.7%
2027 (forecast) $32.1 Mn +$3.1 Mn +22.5%
2028 (forecast) $35.6 Mn +$3.4 Mn +35.7%
2029 (forecast) $39.4 Mn +$3.8 Mn +50.2%
2030 (forecast) $43.6 Mn +$4.2 Mn +66.2%
2031 (forecast) $48.3 Mn +$4.7 Mn +84%
2032 (forecast) $53.4 Mn +$5.2 Mn +103.7%
2033 (forecast) $59.1 Mn +$5.7 Mn +125.5%
2034 (forecast) $65.5 Mn +$6.3 Mn +149.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

France Leadless Pacemakers Market Analysis at a glance
Market size, 2025$26.2 Mn placeholder estimate
Forecast, 2034$65.5 Mn placeholder estimate
Growth (CAGR), 2025–203410.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, application and end user (see all)
Key playersMedtronic, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG (see all)
Regulator in FranceANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026.
Active clinical trials2 in FranceSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France Leadless Pacemakers Market Analysis Executive Summary

Leadless pacemakers are tiny pacemakers placed directly inside the heart through a vein, with no wires under the skin.

Key segments of the leadless Pacemakers market include type (Single-Chamber and Dual-Chamber) and application (Bradycardia and AV Block).

Bar chart: France Leadless Pacemakers market size, 2024–2034, placeholder estimates. $23.7 Mn in 2024, $26.2 Mn in 2025 and $65.5 Mn in 2034, 10.7% CAGR.
France Leadless Pacemakers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France Leadless Pacemakers Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the leadless Pacemakers market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the leadless Pacemakers market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the leadless Pacemakers market.

Competitive Landscape for Leadless Pacemakers Market in France

The leadless Pacemakers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Leadless Pacemakers Market in France

Leadless Pacemakers in France: rules, payment and research

Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2] ClinicalTrials.gov lists 2 studies on Leadless Pacemakers that are recruiting, active or about to start in France.⁠[3] Early deaths from long-term diseases: 9.7% in 2023, the latest WHO figure for France.⁠[4]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how leadless Pacemakers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Leadless Pacemakers right now, from free public sources.

Clinical trials

2 active trials in France

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Abbott Laboratories 5 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Medtronic 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Leadless Pacemakers in context

France compared

  • Early deaths from long-term diseases: 9.7% (2023). World: 17.2% (2023). 4th highest of the 6 countries we cover in Europe.[1]
  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 3rd highest of the 6 countries we cover in Europe.[2]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 6th highest of the 6 countries we cover in Europe.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

Free data on this topic

Inside France

Quick answers

Frequently asked questions

How big is the Leadless Pacemakers market in France?
Placeholder estimate: about $26.2 Mn in 2025, rising to about $65.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Leadless Pacemakers market in France growing?
Placeholder estimate: about 10.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Leadless Pacemakers market report cover?
The report splits the market by type (Single-Chamber, Dual-Chamber), application (Bradycardia, AV Block) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Leadless Pacemakers market?
Key players include Medtronic, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation and Biotronik SE & Co. KG.
What is driving the Leadless Pacemakers market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the leadless Pacemakers market.
Who regulates Leadless Pacemakers in France?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France. Source: ANSM, French medicines agency. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
How many clinical trials on Leadless Pacemakers are running in France?
2 studies are recruiting, active or about to start in France, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.
What does WHO report for France?
Early deaths from long-term diseases: 9.7% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in France are 65 or older?
22.5% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 18 Nov 2026.
Back to Catalogue

Related Medical Devices reports in France

See all

Related on cardiovascular

See the topic